BACKGROUND: Current literature suggests that racial/ethnic minority survivors may be more likely than whites to experience economic hardship after a cancer diagnosis; however, little is known about such hardship. METHODS: Patients with lung cancer (LC) and colorectal cancer (CRC) participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium were surveyed approximately 4 months (baseline) and 12 months (follow-up) after diagnosis. Economic hardship at follow-up was present if participants 1) indicated difficulty living on household income; and/or 2) for the following 2 months, anticipated experiencing hardships (inadequate housing, food, or medical attention) or reducing living standards to the bare necessities of life. The authors tested whether African Americans (AAs) and Hispanics were more likely than whites to experience economic hardship controlling for sex, age, education, marital status, cancer stage, treatment, and economic status at baseline (income, prescription drug coverage). RESULTS: Of 3432 survivors (39.7% with LC, 60.3% with CRC), 14% were AA, 7% were Hispanic, and 79% were white. AAs and Hispanics had lower education and income than whites. Approximately 68% of AAs, 58% of Hispanics, and 44.5% of whites reported economic hardship. In LC survivors, the Hispanic-white disparity was not significant in unadjusted or adjusted analyses, and the AA-white disparity was explained by baseline economic status. In CRC survivors, the Hispanic-white disparity was explained by baseline economic status, and the AA-white disparity was not explained by the variables that were included in the model. CONCLUSIONS: Economic hardship was evident in almost 1 in 2 cancer survivors 1 year after diagnosis, especially AAs. Research should evaluate and address risk factors and their impact on survival and survivorship outcomes.
BACKGROUND: Current literature suggests that racial/ethnic minority survivors may be more likely than whites to experience economic hardship after a cancer diagnosis; however, little is known about such hardship. METHODS:Patients with lung cancer (LC) and colorectal cancer (CRC) participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium were surveyed approximately 4 months (baseline) and 12 months (follow-up) after diagnosis. Economic hardship at follow-up was present if participants 1) indicated difficulty living on household income; and/or 2) for the following 2 months, anticipated experiencing hardships (inadequate housing, food, or medical attention) or reducing living standards to the bare necessities of life. The authors tested whether African Americans (AAs) and Hispanics were more likely than whites to experience economic hardship controlling for sex, age, education, marital status, cancer stage, treatment, and economic status at baseline (income, prescription drug coverage). RESULTS: Of 3432 survivors (39.7% with LC, 60.3% with CRC), 14% were AA, 7% were Hispanic, and 79% were white. AAs and Hispanics had lower education and income than whites. Approximately 68% of AAs, 58% of Hispanics, and 44.5% of whites reported economic hardship. In LC survivors, the Hispanic-white disparity was not significant in unadjusted or adjusted analyses, and the AA-white disparity was explained by baseline economic status. In CRC survivors, the Hispanic-white disparity was explained by baseline economic status, and the AA-white disparity was not explained by the variables that were included in the model. CONCLUSIONS: Economic hardship was evident in almost 1 in 2 cancer survivors 1 year after diagnosis, especially AAs. Research should evaluate and address risk factors and their impact on survival and survivorship outcomes.
Authors: Kenneth M Langa; A Mark Fendrick; Michael E Chernew; Mohammed U Kabeto; Kerry L Paisley; James A Hayman Journal: Value Health Date: 2004 Mar-Apr Impact factor: 5.725
Authors: Maria Pisu; Andres Azuero; Karen Meneses; Jeffrey Burkhardt; Patrick McNees Journal: Breast Cancer Res Treat Date: 2010-10-26 Impact factor: 4.872
Authors: Ahsan M Arozullah; Elizabeth A Calhoun; Michael Wolf; Denise K Finley; Karen A Fitzner; Elizabeth A Heckinger; Nicolle S Gorby; Glen T Schumock; Charles L Bennett Journal: J Support Oncol Date: 2004 May-Jun
Authors: S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy Journal: Oncologist Date: 2013-02-26
Authors: Theresa A Hastert; Jaclyn M Kyko; Amanda R Reed; Felicity W K Harper; Jennifer L Beebe-Dimmer; Tara E Baird; Ann G Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-05-06 Impact factor: 4.254
Authors: Matthew P Banegas; Jennifer L Schneider; Alison J Firemark; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Alexandra M Varga; Lisa A Waiwaiole; Stephanie M Nutt; Aditi Narayan; K Robin Yabroff Journal: J Cancer Surviv Date: 2019-05-23 Impact factor: 4.442
Authors: Jean A McDougall; Matthew P Banegas; Charles L Wiggins; Vi K Chiu; Ashwani Rajput; Anita Y Kinney Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-03-28 Impact factor: 4.254
Authors: Theresa A Hastert; Matthew P Banegas; Lauren M Hamel; Amanda R Reed; Tara Baird; Jennifer L Beebe-Dimmer; Ann G Schwartz Journal: J Cancer Surviv Date: 2019-05-29 Impact factor: 4.442
Authors: Alem A Belachew; Monica E Reyes; Yuanqing Ye; Gottumukkala S Raju; M Alma Rodriguez; Xifeng Wu; Michelle A T Hildebrandt Journal: Qual Life Res Date: 2020-07-03 Impact factor: 4.147
Authors: Matthew P Banegas; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Stephanie Nutt; Loyce Pace; Alexandra Varga; Lisa Waiwaiole; Jennifer Schneider; K Robin Yabroff Journal: J Cancer Surviv Date: 2017-08-29 Impact factor: 4.442
Authors: Lauren M Hamel; Louis A Penner; Susan Eggly; Robert Chapman; Justin F Klamerus; Michael S Simon; Sarah C E Stanton; Terrance L Albrecht Journal: J Oncol Pract Date: 2016-12-13 Impact factor: 3.840
Authors: K Robin Yabroff; Emily C Dowling; Gery P Guy; Matthew P Banegas; Amy Davidoff; Xuesong Han; Katherine S Virgo; Timothy S McNeel; Neetu Chawla; Danielle Blanch-Hartigan; Erin E Kent; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Zhiyuan Zheng; Ahmedin Jemal; Donatus U Ekwueme Journal: J Clin Oncol Date: 2015-12-07 Impact factor: 44.544
Authors: Marianne M Casilla-Lennon; Seul Ki Choi; Allison M Deal; Jeannette T Bensen; Gopal Narang; Pauline Filippou; Benjamin McCormick; Raj Pruthi; Eric Wallen; Hung-Jui Tan; Michael Woods; Matthew Nielsen; Angela Smith Journal: J Urol Date: 2017-11-16 Impact factor: 7.450